Bank of America’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Bank of America’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5	Closed	-$86	–	8064
2023 Q1	$86	Buy	5 +3	+150%	+$56	﹤0.01%	7489
2022 Q4	$36	Buy	+2	New	+$35	﹤0.01%	7865

Other funds holding ZIVO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.9B AUM 36.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America's ZIVO Position: Q2 2023 in Review

Bank of America sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q2 2023, closing a stake of 5 shares — an estimated $86 sold.

Bank of America first reported a position in ZIVO in Q4 2022 and held it in 2 quarters. The position peaked at $86 in Q1 2023. 12 funds tracked by Wall St. Rank hold ZIVO as of Q2 2023.

Bank of America reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Bank of America sold 5 Zivo Bioscience, Inc. Common Stock shares in Q2 2023, an estimated $86.
Bank of America first reported a position in Zivo Bioscience, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
Bank of America's Zivo Bioscience, Inc. Common Stock position peaked at $86 in Q1 2023.
12 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q2 2023.

Based on Bank of America's 13F filing for Q2 2023, filed 14 Aug 2023.